output stringlengths 5 24.3k | instruction stringlengths 33 308 | system stringclasses 1 value |
|---|---|---|
1. Cardiovascular Diseases [mortality, *prevention & control]; 2. Cholesterol [blood]; 3. Primary Prevention [*methods]; 4. Randomized Controlled Trials as Topic; 5. Risk Assessment [methods]; 6. Risk Factors; 7. Stroke [mortality]; | Provide MESH terms for the study
Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *International Normalized Ratio; 2. *Nomograms; 3. Anticoagulants [*administration & dosage]; 4. Pulmonary Embolism [drug therapy]; 5. Time Factors; 6. Venous Thromboembolism [*drug therapy]; 7. Venous Thrombosis [drug therapy]; 8. Warfarin [*administration & dosage]; | Provide MESH terms for the study
Warfarin initiation nomograms for venous thromboembolism | You are a research assistant. Based on the question please provide appropriate answers |
1. *Anesthesia, General; 2. Angiotensin II Type 1 Receptor Blockers [*therapeutic use]; 3. Angiotensin‐Converting Enzyme Inhibitors [*therapeutic use]; 4. Cardiac Surgical Procedures [adverse effects, *mortality]; 5. Cause of Death; 6. Cerebrovascular Disorders [prevention & control]; 7. Heart Failure [prevention & control]; 8. Hypertension [*drug therapy]; 9. Hypotension [prevention & control]; 10. Length of Stay; 11. Myocardial Infarction [prevention & control]; 12. Perioperative Care [*methods, mortality]; 13. Randomized Controlled Trials as Topic; 14. Renal Insufficiency [prevention & control]; 15. Surgical Procedures, Operative [mortality]; 16. Vascular Surgical Procedures [adverse effects, *mortality]; | Provide MESH terms for the study
Perioperative angiotensin‐converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Inflammatory Agents [adverse effects, *therapeutic use]; 2. Cardiovascular Diseases [mortality, *prevention & control]; 3. Cause of Death; 4. Colchicine [adverse effects, *therapeutic use]; 5. Heart Failure [prevention & control]; 6. Myocardial Infarction [mortality, prevention & control]; 7. Randomized Controlled Trials as Topic; 8. Risk; 9. Stroke [mortality, prevention & control]; | Provide MESH terms for the study
Colchicine for prevention of cardiovascular events | You are a research assistant. Based on the question please provide appropriate answers |
1. *Wound Healing; 2. Clinical Enzyme Tests; 3. Peptide Hydrolases [*analysis]; 4. Varicose Ulcer [*enzymology, *therapy]; | Provide MESH terms for the study
A 'test and treat' strategy for elevated wound protease activity for healing in venous leg ulcers | You are a research assistant. Based on the question please provide appropriate answers |
1. *Internet; 2. *Life Style; 3. Coronary Artery Disease [*prevention & control, rehabilitation]; 4. Diet; 5. Exercise; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Risk Reduction Behavior; 9. Secondary Prevention [*methods]; | Provide MESH terms for the study
Internet‐based interventions for the secondary prevention of coronary heart disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Practice Patterns, Nurses'; 2. Adrenergic beta‐Antagonists [*administration & dosage]; 3. Angiotensin Receptor Antagonists [*administration & dosage]; 4. Angiotensin‐Converting Enzyme Inhibitors [*administration & dosage]; 5. Cause of Death; 6. Dose‐Response Relationship, Drug; 7. Drug Monitoring [*nursing]; 8. Heart Failure [*drug therapy, mortality, *nursing, physiopathology]; 9. Hospitalization [statistics & numerical data]; 10. Randomized Controlled Trials as Topic; 11. Stroke Volume; 12. Time Factors; | Provide MESH terms for the study
Nurse‐led titration of angiotensin converting enzyme inhibitors, beta‐adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction | You are a research assistant. Based on the question please provide appropriate answers |
1. Amiodarone [*therapeutic use]; 2. Anti-Arrhythmia Agents [*therapeutic use]; 3. Cause of Death; 4. Death, Sudden, Cardiac [*prevention & control]; 5. *Primary Prevention; 6. Randomized Controlled Trials as Topic; 7. *Secondary Prevention; 8. Vasodilator Agents [therapeutic use]; | Provide MESH terms for the study
Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death | You are a research assistant. Based on the question please provide appropriate answers |
1. Aminophylline [*therapeutic use]; 2. Bradycardia [complications]; 3. Cardiotonic Agents [*therapeutic use]; 4. Injections, Intravenous; 5. Out-of-Hospital Cardiac Arrest [*drug therapy, etiology, mortality]; 6. Randomized Controlled Trials as Topic; 7. Survival Analysis; | Provide MESH terms for the study
Aminophylline for bradyasystolic cardiac arrest in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Chronic Disease; 2. Heart Failure [mortality, *therapy]; 3. Hospitalization [statistics & numerical data]; 4. Length of Stay [statistics & numerical data]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Telemetry [*methods]; 8. *Telephone; | Provide MESH terms for the study
Structured telephone support or non‐invasive telemonitoring for patients with heart failure | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticholesteremic Agents [*therapeutic use]; 2. Bezafibrate [therapeutic use]; 3. Cardiovascular Diseases [mortality, *prevention & control]; 4. Cause of Death; 5. Cholesterol, HDL; 6. Clofibrate [therapeutic use]; 7. Coronary Disease [mortality]; 8. Fenofibrate [therapeutic use]; 9. Fibric Acids [adverse effects, *therapeutic use]; 10. Gemfibrozil [therapeutic use]; 11. Hypertriglyceridemia [drug therapy]; 12. Myocardial Infarction [mortality, prevention & control]; 13. Randomized Controlled Trials as Topic; 14. Secondary Prevention [*methods]; 15. Stroke [mortality, prevention & control]; | Provide MESH terms for the study
Fibrates for secondary prevention of cardiovascular disease and stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. *Defibrillators, Implantable [adverse effects]; 2. Adrenergic beta‐Antagonists [adverse effects, *therapeutic use]; 3. Brugada Syndrome [etiology, *therapy]; 4. Channelopathies [complications, *therapy]; 5. Death, Sudden, Cardiac [etiology, *prevention & control]; 6. Heart Diseases [therapy]; 7. Randomized Controlled Trials as Topic; 8. Secondary Prevention [*methods]; | Provide MESH terms for the study
Implantable defibrillators versus medical therapy for cardiac channelopathies | You are a research assistant. Based on the question please provide appropriate answers |
1. Aortic Aneurysm, Thoracic [*surgery]; 2. Endovascular Procedures [*methods]; 3. Stents [*classification]; | Provide MESH terms for the study
Stent graft types for endovascular repair of thoracic aortic aneurysms | You are a research assistant. Based on the question please provide appropriate answers |
1. Bandages, Hydrocolloid; 2. Borates [therapeutic use]; 3. Debridement [*methods]; 4. Hydrogel, Polyethylene Glycol Dimethacrylate [therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Sodium Hypochlorite [therapeutic use]; 7. Varicose Ulcer [*therapy]; 8. Wound Healing; | Provide MESH terms for the study
Debridement for venous leg ulcers | You are a research assistant. Based on the question please provide appropriate answers |
1. *Septal Occluder Device; 2. Anticoagulants [*therapeutic use]; 3. Fibrinolytic Agents [therapeutic use]; 4. Foramen Ovale, Patent [complications, drug therapy, *therapy]; 5. Ischemic Attack, Transient [etiology, *prevention & control]; 6. Platelet Aggregation Inhibitors [therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Recurrence; 9. Risk Assessment; 10. Secondary Prevention [*methods]; 11. Stroke [etiology, *prevention & control]; | Provide MESH terms for the study
Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic alpha‐1 Receptor Antagonists [*therapeutic use]; 2. Adrenergic beta‐Antagonists [*therapeutic use]; 3. Antihypertensive Agents [*therapeutic use]; 4. Blood Pressure [*drug effects]; 5. Carbazoles [therapeutic use]; 6. Carvedilol; 7. Essential Hypertension; 8. Heart Rate [drug effects]; 9. Hypertension [*drug therapy]; 10. Labetalol [therapeutic use]; 11. Propanolamines [therapeutic use]; 12. Randomized Controlled Trials as Topic; 13. Withholding Treatment; | Provide MESH terms for the study
Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Arrhythmia Agents [*therapeutic use]; 2. Arrhythmias, Cardiac [mortality, *prevention & control]; 3. Bradycardia [mortality, prevention & control]; 4. Lidocaine [*therapeutic use]; 5. Myocardial Infarction [*complications, mortality]; 6. Randomized Controlled Trials as Topic; 7. Ventricular Fibrillation [mortality, prevention & control]; | Provide MESH terms for the study
Prophylactic lidocaine for myocardial infarction | You are a research assistant. Based on the question please provide appropriate answers |
1. China; 2. Platelet Aggregation Inhibitors [*therapeutic use]; 3. Pyrrolidines [*therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Stroke [*drug therapy, mortality]; | Provide MESH terms for the study
Buflomedil for acute ischaemic stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. *Negative‐Pressure Wound Therapy; 2. Leg Ulcer [*therapy]; 3. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Negative pressure wound therapy for treating leg ulcers | You are a research assistant. Based on the question please provide appropriate answers |
1. Blood Loss, Surgical [prevention & control]; 2. Cardiovascular Surgical Procedures [*mortality]; 3. Elective Surgical Procedures [mortality]; 4. Erythrocyte Transfusion; 5. *Hemostasis, Surgical; 6. *Plasma; 7. Randomized Controlled Trials as Topic; 8. Risk Assessment; | Provide MESH terms for the study
Fresh frozen plasma for cardiovascular surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Coronary Disease; 2. *Myocardial Infarction; 3. Distance Counseling; 4. Motivation; 5. Obesity [therapy]; 6. Randomized Controlled Trials as Topic; 7. Risk Factors; 8. Sedentary Behavior; 9. Self Care; 10. Smoking Cessation [*methods, psychology]; 11. Telephone; 12. Time Factors; | Provide MESH terms for the study
Psychosocial interventions for smoking cessation in patients with coronary heart disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Antidepressive Agents [therapeutic use]; 2. Drugs, Chinese Herbal [therapeutic use]; 3. Fatigue [etiology, *therapy]; 4. Mindfulness [methods]; 5. Randomized Controlled Trials as Topic; 6. Stress, Psychological [prevention & control]; 7. Stroke [*complications, psychology]; | Provide MESH terms for the study
Interventions for post‐stroke fatigue | You are a research assistant. Based on the question please provide appropriate answers |
1. Behavior Therapy; 2. Chest Pain [*psychology, therapy]; 3. Cognitive Behavioral Therapy [*methods]; 4. Coronary Vessels [*anatomy & histology]; 5. Hypnosis; 6. Microvascular Angina [psychology, therapy]; 7. Psychotherapy [methods]; 8. Randomized Controlled Trials as Topic; 9. Recurrence; 10. Treatment Outcome; | Provide MESH terms for the study
Psychological interventions for symptomatic management of non‐specific chest pain in patients with normal coronary anatomy | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [therapeutic use]; 2. Cardiac Surgical Procedures [*adverse effects, statistics & numerical data]; 3. Hemorrhage [chemically induced]; 4. Heparin [therapeutic use]; 5. Primary Prevention [*methods]; 6. Randomized Controlled Trials as Topic; 7. Stockings, Compression; 8. Thoracic Surgical Procedures [*adverse effects, statistics & numerical data]; 9. Venous Thromboembolism [epidemiology, *prevention & control]; | Provide MESH terms for the study
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Activities of Daily Living [psychology]; 2. *Motivation; 3. *Motivational Interviewing; 4. *Stroke Rehabilitation; 5. Randomized Controlled Trials as Topic; 6. Recovery of Function; 7. Stroke [psychology]; | Provide MESH terms for the study
Motivational interviewing for improving recovery after stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Inflammatory Agents [*therapeutic use]; 2. Aspirin [therapeutic use]; 3. Immunoglobulins, Intravenous [therapeutic use]; 4. Myocarditis [*drug therapy]; 5. Randomized Controlled Trials as Topic; 6. Rheumatic Heart Disease [*drug therapy]; 7. Steroids [therapeutic use]; | Provide MESH terms for the study
Anti‐inflammatory treatment for carditis in acute rheumatic fever | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [*administration & dosage, adverse effects]; 2. Blood Pressure [*drug effects]; 3. Dose‐Response Relationship, Drug; 4. Furosemide [administration & dosage, adverse effects]; 5. Hypertension [*drug therapy]; 6. Indans [administration & dosage, adverse effects]; 7. Pyridines [administration & dosage, adverse effects]; 8. Randomized Controlled Trials as Topic; 9. Sodium Potassium Chloride Symporter Inhibitors [*administration & dosage, adverse effects]; 10. Sulfonamides [administration & dosage, adverse effects]; 11. Thiazoles [administration & dosage, adverse effects]; | Provide MESH terms for the study
Blood pressure‐lowering efficacy of loop diuretics for primary hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. *Percutaneous Coronary Intervention; 2. Adenosine [adverse effects, *therapeutic use]; 3. Cause of Death; 4. Myocardial Infarction [mortality, *surgery]; 5. No‐Reflow Phenomenon [*drug therapy, mortality]; 6. Randomized Controlled Trials as Topic; 7. Vasodilator Agents [adverse effects, *therapeutic use]; 8. Verapamil [*therapeutic use]; | Provide MESH terms for the study
Adenosine and verapamil for no‐reflow during primary percutaneous coronary intervention in people with acute myocardial infarction | You are a research assistant. Based on the question please provide appropriate answers |
1. Coronary Disease [mortality, *prevention & control]; 2. Influenza Vaccines [*therapeutic use]; 3. Influenza, Human [prevention & control]; 4. Primary Prevention; 5. Randomized Controlled Trials as Topic; 6. Secondary Prevention; | Provide MESH terms for the study
Influenza vaccines for preventing cardiovascular disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Assisted Circulation [instrumentation, methods]; 2. Intra-Aortic Balloon Pumping [*methods]; 3. Myocardial Infarction [*complications]; 4. Randomized Controlled Trials as Topic; 5. Shock, Cardiogenic [etiology, *therapy]; | Provide MESH terms for the study
Intra‐aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock | You are a research assistant. Based on the question please provide appropriate answers |
1. Anesthetics [*administration & dosage, adverse effects]; 2. Apnea [chemically induced]; 3. Diazepam [administration & dosage, adverse effects]; 4. Electric Countershock [adverse effects, *methods]; 5. Etomidate [administration & dosage, adverse effects]; 6. Fentanyl [administration & dosage, adverse effects]; 7. Hypnotics and Sedatives [*administration & dosage, adverse effects]; 8. Hypotension [chemically induced]; 9. Mental Recall; 10. Methyl Ethers [administration & dosage, adverse effects]; 11. Midazolam [administration & dosage, adverse effects]; 12. Piperidines [administration & dosage, adverse effects]; 13. Propofol [administration & dosage, adverse effects]; 14. Randomized Controlled Trials as Topic; 15. Remifentanil; 16. Sevoflurane; 17. Thiopental [administration & dosage, adverse effects]; | Provide MESH terms for the study
Anaesthetic and sedative agents used for electrical cardioversion | You are a research assistant. Based on the question please provide appropriate answers |
1. *Stroke Rehabilitation; 2. Activities of Daily Living; 3. Environment Design; 4. Gait [physiology]; 5. Randomized Controlled Trials as Topic; 6. Residence Characteristics; 7. Self Efficacy; 8. Time Factors; 9. Walking [*physiology]; | Provide MESH terms for the study
Interventions for improving community ambulation in individuals with stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Atorvastatin; 2. Cholesterol [*blood]; 3. Cholesterol, HDL [blood]; 4. Cholesterol, LDL [blood]; 5. Controlled Before‐After Studies; 6. Dose‐Response Relationship, Drug; 7. Heptanoic Acids [*administration & dosage]; 8. Hydroxymethylglutaryl‐CoA Reductase Inhibitors [*administration & dosage]; 9. Hyperlipidemias [blood, drug therapy]; 10. Lipids [blood]; 11. Pyrroles [*administration & dosage]; 12. Randomized Controlled Trials as Topic; 13. Sex Factors; 14. Triglycerides [blood]; | Provide MESH terms for the study
Atorvastatin for lowering lipids | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Kidney Injury [*prevention & control, therapy]; 2. Atorvastatin; 3. Cardiac Surgical Procedures; 4. Cardiopulmonary Bypass [*adverse effects]; 5. Coronary Artery Bypass [*adverse effects]; 6. Creatinine [blood]; 7. Fluorobenzenes [therapeutic use]; 8. Heptanoic Acids [*therapeutic use]; 9. Hydroxymethylglutaryl‐CoA Reductase Inhibitors [*therapeutic use]; 10. Length of Stay; 11. Pyrimidines [therapeutic use]; 12. Pyrroles [*therapeutic use]; 13. Randomized Controlled Trials as Topic; 14. Renal Replacement Therapy; 15. Rosuvastatin Calcium; 16. Simvastatin [therapeutic use]; 17. Sulfonamides [therapeutic use]; | Provide MESH terms for the study
HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass | You are a research assistant. Based on the question please provide appropriate answers |
1. Angina Pectoris [mortality, *therapy]; 2. Laser Therapy [adverse effects, *methods, mortality]; 3. Myocardial Revascularization [adverse effects, *methods, mortality]; 4. Randomized Controlled Trials as Topic; 5. Thoracotomy; | Provide MESH terms for the study
Transmyocardial laser revascularization versus medical therapy for refractory angina | You are a research assistant. Based on the question please provide appropriate answers |
1. Anastomosis, Surgical [adverse effects, methods]; 2. Anticoagulants [therapeutic use]; 3. Arteriosclerosis [surgery]; 4. Aspirin [therapeutic use]; 5. Dipyridamole [therapeutic use]; 6. Graft Occlusion, Vascular [etiology, *prevention & control]; 7. Intermittent Claudication [surgery]; 8. Peripheral Vascular Diseases [*surgery]; 9. Platelet Aggregation Inhibitors [*therapeutic use]; 10. Randomized Controlled Trials as Topic; 11. Thrombosis [*prevention & control]; 12. Vascular Patency; | Provide MESH terms for the study
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. Randomized Controlled Trials as Topic; 2. Tachycardia, Supraventricular [*therapy]; 3. Treatment Outcome; 4. Valsalva Maneuver [*physiology]; | Provide MESH terms for the study
Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Adrenergic beta‐Antagonists [administration & dosage, *therapeutic use]; 3. Cardiovascular Diseases [*prevention & control]; 4. Cause of Death; 5. Injections, Intravenous; 6. Metoprolol [administration & dosage, *therapeutic use]; 7. Postoperative Complications [mortality, *prevention & control]; 8. Randomized Controlled Trials as Topic; 9. Risk Reduction Behavior; 10. Vascular Surgical Procedures [*adverse effects]; | Provide MESH terms for the study
Beta‐adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. Fluorobenzenes [adverse effects, *therapeutic use]; 2. Hydroxymethylglutaryl‐CoA Reductase Inhibitors [adverse effects, *therapeutic use]; 3. Myocardial Infarction [prevention & control]; 4. Pyrimidines [adverse effects, *therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Rosuvastatin Calcium; 7. Stroke [prevention & control]; 8. Sulfonamides [adverse effects, *therapeutic use]; 9. Venous Thromboembolism [*prevention & control]; 10. Venous Thrombosis [prevention & control]; | Provide MESH terms for the study
Statins for primary prevention of venous thromboembolism | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [therapeutic use]; 2. Behcet Syndrome [complications, *drug therapy]; 3. Biological Products [therapeutic use]; 4. Central Nervous System Diseases [*drug therapy, etiology]; 5. Colchicine [therapeutic use]; 6. Immunosuppressive Agents [therapeutic use]; 7. Interferon‐alpha [therapeutic use]; | Provide MESH terms for the study
Biologics, colchicine, corticosteroids, immunosuppressants and interferon‐alpha for Neuro‐Behçet's Syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. *Angioplasty, Balloon; 2. *Stents; 3. Antihypertensive Agents [*therapeutic use]; 4. Combined Modality Therapy [methods]; 5. Hypertension [*therapy]; 6. Randomized Controlled Trials as Topic; 7. Renal Artery Obstruction [*therapy]; | Provide MESH terms for the study
Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐1 Receptor Antagonists [*therapeutic use]; 2. Antihypertensive Agents [*therapeutic use]; 3. Blood Pressure [*drug effects]; 4. Dose‐Response Relationship, Drug; 5. Essential Hypertension; 6. Heart Rate [drug effects]; 7. Hypertension [*drug therapy]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. Cardiovascular Diseases [blood]; 2. Cholesterol [blood]; 3. Cholesterol, HDL [blood]; 4. Cholesterol, LDL [blood]; 5. Dose‐Response Relationship, Drug; 6. Drug Administration Schedule; 7. Fluorobenzenes [*administration & dosage]; 8. Hydroxymethylglutaryl‐CoA Reductase Inhibitors [*administration & dosage]; 9. Hyperlipidemias [blood, *drug therapy]; 10. Lipids [*blood]; 11. Pyrimidines [*administration & dosage]; 12. Randomized Controlled Trials as Topic; 13. Rosuvastatin Calcium; 14. Sulfonamides [*administration & dosage]; 15. Triglycerides [blood]; | Provide MESH terms for the study
Rosuvastatin for lowering lipids | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Blood Pressure [*drug effects]; 3. Calcium Channel Blockers [*therapeutic use]; 4. Hypertension [drug therapy]; 5. Randomized Controlled Trials as Topic; 6. Risk; 7. Stroke [physiopathology, *prevention & control]; 8. Time‐to‐Treatment [statistics & numerical data]; 9. Vasodilator Agents [*therapeutic use]; | Provide MESH terms for the study
Interventions for deliberately altering blood pressure in acute stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Cardiopulmonary Resuscitation [*methods, mortality]; 2. Combined Modality Therapy [methods, mortality]; 3. Electric Countershock [*methods, mortality]; 4. Out‐of‐Hospital Cardiac Arrest [mortality, *therapy]; 5. Randomized Controlled Trials as Topic; 6. Time Factors; | Provide MESH terms for the study
Cardiopulmonary resuscitation (CPR) plus delayed defibrillation versus immediate defibrillation for out‐of‐hospital cardiac arrest | You are a research assistant. Based on the question please provide appropriate answers |
1. *Emergency Medical Services; 2. *Thrombolytic Therapy [adverse effects, mortality]; 3. Fibrinolytic Agents [*administration & dosage, adverse effects]; 4. Hemorrhage [chemically induced]; 5. Myocardial Infarction [*drug therapy, mortality]; 6. Randomized Controlled Trials as Topic; 7. Time‐to‐Treatment; | Provide MESH terms for the study
Pre‐hospital versus in‐hospital thrombolysis for ST‐elevation myocardial infarction | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [administration & dosage, *therapeutic use]; 2. Blood Pressure [*drug effects, physiology]; 3. Calcium Channel Blockers [*therapeutic use]; 4. Circadian Rhythm; 5. Dihydropyridines [administration & dosage, *therapeutic use]; 6. Drug Administration Schedule; 7. Hypertension [*drug therapy]; 8. Randomized Controlled Trials as Topic; 9. Time Factors; | Provide MESH terms for the study
Time course for blood pressure lowering of dihydropyridine calcium channel blockers | You are a research assistant. Based on the question please provide appropriate answers |
1. Angiotensin Receptor Antagonists [adverse effects, *therapeutic use]; 2. Angiotensin‐Converting Enzyme Inhibitors [adverse effects, *therapeutic use]; 3. Antihypertensive Agents [adverse effects, *therapeutic use]; 4. Essential Hypertension; 5. Heart Diseases [mortality]; 6. Hypertension [complications, *drug therapy, mortality]; 7. Hypotension; 8. Randomized Controlled Trials as Topic; 9. Stroke [mortality]; | Provide MESH terms for the study
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. *Exercise; 2. Blood Pressure; 3. Body Mass Index; 4. Cardiovascular Diseases [blood, *prevention & control]; 5. Cholesterol, HDL [blood]; 6. Cholesterol, LDL [blood]; 7. Exercise Tolerance; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Risk Factors; 11. Smoking; | Provide MESH terms for the study
Exercise for people with high cardiovascular risk | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Coronary Syndrome [*drug therapy, mortality]; 2. Angina, Unstable [drug therapy]; 3. Anticoagulants [adverse effects, *therapeutic use]; 4. Heparin [adverse effects, *therapeutic use]; 5. Heparin, Low-Molecular-Weight [adverse effects, therapeutic use]; 6. Myocardial Infarction [prevention & control]; 7. Placebos [therapeutic use]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Heparin versus placebo for non‐ST elevation acute coronary syndromes | You are a research assistant. Based on the question please provide appropriate answers |
1. *Femoral Artery; 2. *Stents; 3. Angioplasty, Balloon [*methods]; 4. Anticoagulants [therapeutic use]; 5. Combined Modality Therapy [methods]; 6. Intermittent Claudication [therapy]; 7. Peripheral Vascular Diseases [*therapy]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Vascular Patency; | Provide MESH terms for the study
Angioplasty versus bare metal stenting for superficial femoral artery lesions | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [adverse effects, *therapeutic use]; 2. Hypertension, Pulmonary [*drug therapy]; 3. International Normalized Ratio; 4. Placebos [therapeutic use]; | Provide MESH terms for the study
Anticoagulation therapy versus placebo for pulmonary hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [*administration & dosage, adverse effects]; 2. Blood Pressure [drug effects]; 3. Chlorthalidone [administration & dosage, adverse effects]; 4. Essential Hypertension; 5. Hydrochlorothiazide [administration & dosage, adverse effects]; 6. Hypertension [*drug therapy]; 7. Indapamide [administration & dosage, adverse effects]; 8. Randomized Controlled Trials as Topic; 9. Sodium Chloride Symporter Inhibitors [*administration & dosage, adverse effects]; | Provide MESH terms for the study
Blood pressure‐lowering efficacy of monotherapy with thiazide diuretics for primary hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. Chagas Cardiomyopathy [prevention & control]; 2. Chagas Disease [*drug therapy]; 3. Chronic Disease; 4. Observational Studies as Topic; 5. Randomized Controlled Trials as Topic; 6. Trypanocidal Agents [*therapeutic use]; 7. Trypanosoma cruzi; | Provide MESH terms for the study
Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Ankle Brachial Index; 3. Anticoagulants [adverse effects, *therapeutic use]; 4. Hemorrhage [chemically induced]; 5. Heparin [adverse effects, therapeutic use]; 6. Heparin, Low‐Molecular‐Weight [adverse effects, therapeutic use]; 7. Intermittent Claudication [*drug therapy]; 8. Prospective Studies; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication | You are a research assistant. Based on the question please provide appropriate answers |
1. Amputation, Surgical [*methods]; 2. Diabetic Foot [*surgery]; 3. Gangrene [complications, surgery]; 4. Ischemia [*surgery]; 5. Leg [*blood supply]; 6. Randomized Controlled Trials as Topic; 7. Reoperation; 8. Surgical Flaps; 9. Treatment Outcome; 10. Wound Healing; | Provide MESH terms for the study
Type of incision for below knee amputation | You are a research assistant. Based on the question please provide appropriate answers |
1. Amidines [therapeutic use]; 2. Antithrombins [adverse effects, *therapeutic use]; 3. Atrial Fibrillation [*complications]; 4. Azetidines [adverse effects, therapeutic use]; 5. Benzimidazoles [therapeutic use]; 6. Benzylamines [adverse effects, therapeutic use]; 7. Dabigatran; 8. Drug Administration Schedule; 9. Embolism [etiology, *prevention & control]; 10. Randomized Controlled Trials as Topic; 11. Safety‐Based Drug Withdrawals; 12. Stroke [etiology, *prevention & control]; 13. Vitamin K [*antagonists & inhibitors]; 14. Warfarin [therapeutic use]; 15. beta‐Alanine [analogs & derivatives, therapeutic use]; | Provide MESH terms for the study
Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non‐valvular atrial fibrillation | You are a research assistant. Based on the question please provide appropriate answers |
1. Abciximab; 2. Antibodies, Monoclonal [adverse effects, *therapeutic use]; 3. Aspirin [adverse effects, *therapeutic use]; 4. Brain Ischemia [drug therapy]; 5. Immunoglobulin Fab Fragments [adverse effects, *therapeutic use]; 6. Intracranial Hemorrhages [chemically induced]; 7. Platelet Aggregation Inhibitors [adverse effects, *therapeutic use]; 8. Platelet Glycoprotein GPIIb-IIIa Complex [*antagonists & inhibitors]; 9. Randomized Controlled Trials as Topic; 10. Stroke [*drug therapy]; 11. Tirofiban; 12. Tyrosine [adverse effects, *analogs & derivatives, therapeutic use]; | Provide MESH terms for the study
Glycoprotein IIb‐IIIa inhibitors for acute ischaemic stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibiotic Prophylaxis [adverse effects, *methods]; 2. Antitubercular Agents [adverse effects, *therapeutic use]; 3. Chemical and Drug Induced Liver Injury [etiology]; 4. Hepatitis B [complications]; 5. Hepatitis C [complications]; 6. Immunosuppression Therapy [adverse effects]; 7. Isoniazid [adverse effects, *therapeutic use]; 8. Kidney Transplantation [*adverse effects]; 9. Tuberculosis [*prevention & control]; | Provide MESH terms for the study
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Androstenes [adverse effects]; 2. Contraceptives, Oral, Combined [*adverse effects]; 3. Cyproterone [adverse effects]; 4. Desogestrel [adverse effects]; 5. Ethinyl Estradiol [adverse effects]; 6. Levonorgestrel [adverse effects]; 7. Norpregnenes [adverse effects]; 8. Pulmonary Embolism [*chemically induced]; 9. Randomized Controlled Trials as Topic; 10. Venous Thrombosis [*chemically induced]; | Provide MESH terms for the study
Combined oral contraceptives: venous thrombosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐Antagonists [*pharmacology]; 2. Antihypertensive Agents [pharmacology]; 3. Blood Pressure [*drug effects]; 4. Dose‐Response Relationship, Drug; 5. Heart Rate [drug effects]; 6. Hypertension [*drug therapy]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Blood pressure lowering efficacy of nonselective beta‐blockers for primary hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐Antagonists [*therapeutic use]; 2. Antihypertensive Agents [*therapeutic use]; 3. Aortic Aneurysm, Thoracic [*drug therapy, etiology]; 4. Aortic Dissection [*drug therapy, etiology]; 5. Hypertension [complications, drug therapy]; | Provide MESH terms for the study
First‐line beta‐blockers versus other antihypertensive medications for chronic type B aortic dissection | You are a research assistant. Based on the question please provide appropriate answers |
1. Blood Glucose [*metabolism]; 2. Diabetes Mellitus [mortality]; 3. Hyperglycemia [blood, complications, *drug therapy, mortality]; 4. Hypoglycemia [blood, complications, mortality]; 5. Hypoglycemic Agents [*administration & dosage]; 6. Insulin [*administration & dosage]; 7. Prognosis; 8. Randomized Controlled Trials as Topic; 9. Reference Values; 10. Stroke [*blood, complications]; | Provide MESH terms for the study
Insulin for glycaemic control in acute ischaemic stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Aortic Aneurysm, Abdominal [*surgery]; 2. Aortic Rupture [prevention & control]; 3. Cause of Death; 4. Endovascular Procedures [adverse effects, *methods, mortality]; 5. Randomized Controlled Trials as Topic; 6. Reoperation [statistics & numerical data]; 7. Watchful Waiting; | Provide MESH terms for the study
Endovascular repair of abdominal aortic aneurysm | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [*therapeutic use]; 2. Anti‐Infective Agents, Local [*therapeutic use]; 3. Occlusive Dressings; 4. Randomized Controlled Trials as Topic; 5. Varicose Ulcer [*drug therapy, microbiology]; 6. Wound Healing; | Provide MESH terms for the study
Antibiotics and antiseptics for venous leg ulcers | You are a research assistant. Based on the question please provide appropriate answers |
1. Angioplasty; 2. Brachytherapy [*methods]; 3. Endovascular Procedures [*methods]; 4. Femoral Artery; 5. Peripheral Vascular Diseases [*radiotherapy, therapy]; 6. Popliteal Artery; 7. Quality of Life; 8. Radiotherapy, Adjuvant; 9. Randomized Controlled Trials as Topic; 10. Stents; 11. Vascular Patency; | Provide MESH terms for the study
Intravascular brachytherapy for peripheral vascular disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [*therapeutic use]; 2. Hypertension [complications, *drug therapy]; 3. Intermittent Claudication [complications, drug therapy]; 4. Peripheral Vascular Diseases [complications, *drug therapy]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Treatment of hypertension in peripheral arterial disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Heart Transplantation; 2. Antibodies, Monoclonal [immunology, *therapeutic use]; 3. Antibodies, Monoclonal, Humanized [therapeutic use]; 4. Antilymphocyte Serum [immunology]; 5. Basiliximab; 6. Daclizumab; 7. Graft Rejection [immunology, *prevention & control]; 8. Immunoglobulin G [therapeutic use]; 9. Immunosuppression Therapy [*methods]; 10. Muromonab‐CD3 [therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. Receptors, Interleukin‐2 [*antagonists & inhibitors, immunology]; 13. Recombinant Fusion Proteins [therapeutic use]; 14. T‐Lymphocytes [*immunology]; | Provide MESH terms for the study
Immunosuppressive T‐cell antibody induction for heart transplant recipients | You are a research assistant. Based on the question please provide appropriate answers |
1. *Blood Pressure; 2. Diabetic Angiopathies [*drug therapy, mortality]; 3. Diastole; 4. Hypertension [*drug therapy, mortality]; 5. Randomized Controlled Trials as Topic; 6. Reference Values; 7. Stroke [prevention & control]; 8. Systole; | Provide MESH terms for the study
Blood pressure targets for hypertension in people with diabetes mellitus | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Adrenal Cortex Hormones [therapeutic use]; 3. Azathioprine [therapeutic use]; 4. Chronic Disease; 5. Cyclosporine [therapeutic use]; 6. Myocarditis [*drug therapy, enzymology, *virology]; 7. Prednisone [therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Virus Diseases [*drug therapy]; | Provide MESH terms for the study
Corticosteroids for viral myocarditis | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐Antagonists [*adverse effects]; 2. Atenolol [adverse effects]; 3. Intermittent Claudication [*drug therapy]; 4. Metoprolol [adverse effects]; 5. Peripheral Vascular Diseases [*drug therapy]; 6. Pindolol [adverse effects]; 7. Propranolol [adverse effects]; 8. Randomized Controlled Trials as Topic; 9. Regional Blood Flow [drug effects]; 10. Walking; | Provide MESH terms for the study
Beta blockers for peripheral arterial disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Heart Failure [*drug therapy]; 3. Isosorbide Dinitrate [therapeutic use]; 4. Nitrates [*therapeutic use]; 5. Nitroglycerin [therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Syndrome; 8. Vasodilator Agents [*therapeutic use]; | Provide MESH terms for the study
Nitrates for acute heart failure syndromes | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [*administration & dosage, adverse effects]; 2. Drug Administration Schedule; 3. Hemorrhage [chemically induced]; 4. Heparin, Low‐Molecular‐Weight [*administration & dosage, adverse effects]; 5. Pulmonary Embolism [drug therapy]; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. Thromboembolism [*drug therapy]; 9. Venous Thrombosis [*drug therapy]; | Provide MESH terms for the study
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism | You are a research assistant. Based on the question please provide appropriate answers |
1. *Patient Care Team; 2. Botulinum Toxins [*therapeutic use]; 3. Muscle Spasticity [drug therapy, etiology, *rehabilitation]; 4. Neuromuscular Agents [*therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Stroke [*complications, drug therapy]; | Provide MESH terms for the study
Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post‐stroke spasticity | You are a research assistant. Based on the question please provide appropriate answers |
1. *Nursing Homes; 2. *Stroke Rehabilitation; 3. Activities of Daily Living; 4. Disabled Persons [*rehabilitation]; 5. Occupational Therapy [*methods]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Occupational therapy for care home residents with stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. *Bed Rest [mortality]; 2. *Early Ambulation [mortality]; 3. Secondary Prevention; 4. Subarachnoid Hemorrhage [mortality, *prevention & control]; 5. Time Factors; 6. Treatment Outcome; | Provide MESH terms for the study
Early versus delayed mobilisation for aneurysmal subarachnoid haemorrhage | You are a research assistant. Based on the question please provide appropriate answers |
1. Blood Pressure [physiology]; 2. Body Temperature [physiology]; 3. Heart Rate [physiology]; 4. Hospital Units [standards]; 5. Institutionalization; 6. Length of Stay; 7. Monitoring, Physiologic [methods]; 8. Oxygen [metabolism]; 9. Pulse; 10. Quality of Health Care; 11. Randomized Controlled Trials as Topic; 12. Stroke [complications, mortality, *physiopathology]; 13. Time Factors; | Provide MESH terms for the study
Continuous versus intermittent physiological monitoring for acute stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Flavonoids [*therapeutic use]; 2. Hydroxyethylrutoside [therapeutic use]; 3. Randomized Controlled Trials as Topic; 4. Varicose Ulcer [*drug therapy]; | Provide MESH terms for the study
Flavonoids for treating venous leg ulcers | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticholesteremic Agents [*therapeutic use]; 2. Brain Ischemia [epidemiology, *prevention & control]; 3. Incidence; 4. Randomized Controlled Trials as Topic; 5. Simvastatin [*therapeutic use]; 6. Subarachnoid Hemorrhage [complications, *drug therapy]; 7. Treatment Outcome; | Provide MESH terms for the study
Cholesterol‐reducing agents for aneurysmal subarachnoid haemorrhage | You are a research assistant. Based on the question please provide appropriate answers |
1. Hypertension [prevention & control]; 2. Ischemic Attack, Transient [*prevention & control]; 3. Myocardial Infarction [*prevention & control]; 4. Randomized Controlled Trials as Topic; 5. Risk Factors; 6. Secondary Prevention [*methods]; 7. Stroke [*prevention & control]; | Provide MESH terms for the study
Non‐pharmacological interventions for preventing secondary vascular events after stroke or transient ischemic attack | You are a research assistant. Based on the question please provide appropriate answers |
1. *Long‐Term Care; 2. *Rehabilitation; 3. Activities of Daily Living; 4. Cognition Disorders [rehabilitation]; 5. Exercise Therapy; 6. Homes for the Aged; 7. Nursing Homes; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Physical rehabilitation for older people in long‐term care | You are a research assistant. Based on the question please provide appropriate answers |
1. Brain Injuries [*prevention & control]; 2. Heart Arrest [*complications]; 3. Hypothermia, Induced [*methods]; | Provide MESH terms for the study
Hypothermia for neuroprotection in children after cardiopulmonary arrest | You are a research assistant. Based on the question please provide appropriate answers |
1. *Aedes [microbiology]; 2. *Dengue [prevention & control]; 3. *Dengue Virus; 4. Mosquito Vectors [microbiology]; 5. *Wolbachia; | Provide MESH terms for the study
Wolbachia‐carrying Aedes mosquitoes for preventing dengue infection | You are a research assistant. Based on the question please provide appropriate answers |
1. *Chickenpox [chemically induced, drug therapy]; 2. *Herpes Zoster [chemically induced, drug therapy, prevention & control]; 3. *Herpes Zoster Vaccine [adverse effects]; 4. Herpesvirus 3, Human; 5. Vaccines, Attenuated [adverse effects]; | Provide MESH terms for the study
Vaccines for preventing herpes zoster in older adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Aspirin; 2. Asymptomatic Infections; 3. *COVID-19; 4. *Platelet Aggregation Inhibitors; 5. SARS-CoV-2; | Provide MESH terms for the study
Antiplatelet agents for the treatment of adults with COVID‐19 | You are a research assistant. Based on the question please provide appropriate answers |
1. Bicarbonates [therapeutic use]; 2. Creatinine; 3. *Dehydration [etiology, therapy]; 4. Diarrhea [therapy]; 5. *Hypokalemia; 6. Potassium; 7. Potassium Chloride [therapeutic use]; 8. Ringer's Lactate; 9. Saline Solution; 10. Sodium; | Provide MESH terms for the study
Balanced crystalloid solutions versus 0.9% saline for treating acute diarrhoea and severe dehydration in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Immunoglobulins; 2. *Mpox (monkeypox); 3. *Organophosphonates; | Provide MESH terms for the study
Therapeutics for treating mpox in humans | You are a research assistant. Based on the question please provide appropriate answers |
1. *COVID-19 [therapy, virology]; 2. *COVID-19 Serotherapy; 3. *Immunoglobulins [therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. SARS-CoV-2 [genetics]; | Provide MESH terms for the study
Hyperimmune immunoglobulin for people with COVID‐19 | You are a research assistant. Based on the question please provide appropriate answers |
1. *COVID-19; 2. COVID-19 Drug Treatment; 3. Disease Progression; 4. Randomized Controlled Trials as Topic; 5. SARS-CoV-2; | Provide MESH terms for the study
Remdesivir for the treatment of COVID‐19 | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [adverse effects]; 2. *COVID-19 Drug Treatment; 3. Dexamethasone [adverse effects]; 4. *Invasive Fungal Infections; 5. Methylprednisolone; 6. Post-Acute COVID-19 Syndrome; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Systemic corticosteroids for the treatment of COVID‐19: Equity‐related analyses and update on evidence | You are a research assistant. Based on the question please provide appropriate answers |
1. *COVID-19; 2. Ivermectin [adverse effects]; 3. Randomized Controlled Trials as Topic; 4. Respiration, Artificial; 5. SARS-CoV-2; 6. Severity of Illness Index; | Provide MESH terms for the study
Ivermectin for preventing and treating COVID‐19 | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibodies, Monoclonal [adverse effects]; 2. Antibodies, Monoclonal, Humanized; 3. Antibodies, Neutralizing; 4. *Antineoplastic Agents, Immunological; 5. *COVID-19 [prevention & control]; 6. SARS-CoV-2; | Provide MESH terms for the study
SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19 | You are a research assistant. Based on the question please provide appropriate answers |
1. Antiviral Agents [therapeutic use]; 2. *Coinfection; 3. *COVID-19 Drug Treatment; 4. *Janus Kinase Inhibitors [therapeutic use]; 5. Oxygen; 6. Randomized Controlled Trials as Topic; 7. SARS-CoV-2; 8. United States; | Provide MESH terms for the study
Janus kinase inhibitors for the treatment of COVID‐19 | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones; 2. Cause of Death; 3. *COVID-19 Drug Treatment; 4. Respiration, Artificial; 5. SARS-CoV-2; | Provide MESH terms for the study
Inhaled corticosteroids for the treatment of COVID‐19 | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [adverse effects]; 2. Cause of Death; 3. *COVID-19; 4. Respiration, Artificial; 5. SARS-CoV-2; | Provide MESH terms for the study
Antibiotics for the treatment of COVID‐19 | You are a research assistant. Based on the question please provide appropriate answers |
1. Cause of Death; 2. *Colchicine [adverse effects]; 3. *COVID-19; 4. Quality of Life; 5. SARS-CoV-2; | Provide MESH terms for the study
Colchicine for the treatment of COVID‐19 | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibodies, Monoclonal [therapeutic use]; 2. Cause of Death; 3. *COVID-19; 4. Randomized Controlled Trials as Topic; 5. *SARS-CoV-2; | Provide MESH terms for the study
SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19 | You are a research assistant. Based on the question please provide appropriate answers |
1. *Antibiotics, Antitubercular [therapeutic use]; 2. *HIV Infections [complications, drug therapy]; 3. Lipopolysaccharides; 4. *Mycobacterium tuberculosis; 5. Rifampin; 6. Sensitivity and Specificity; 7. *Tuberculosis [diagnosis, drug therapy]; 8. *Tuberculosis, Pulmonary [drug therapy]; | Provide MESH terms for the study
Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV | You are a research assistant. Based on the question please provide appropriate answers |
1. *Lower Urinary Tract Symptoms [surgery, therapy]; 2. Network Meta-Analysis; 3. *Prostatic Hyperplasia [complications, surgery]; 4. Quality of Life; 5. *Transurethral Resection of Prostate [adverse effects]; | Provide MESH terms for the study
Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta‐analysis | You are a research assistant. Based on the question please provide appropriate answers |
1. Albendazole [administration & dosage]; 2. *Anemia, Iron-Deficiency [parasitology, prevention & control]; 3. *Anthelmintics [administration & dosage]; 4. Bias; 5. Helminthiasis [drug therapy, transmission]; 6. *Intestinal Diseases, Parasitic [drug therapy]; 7. Iron Compounds [administration & dosage]; 8. Perinatal Mortality; 9. *Pregnancy Complications, Hematologic [parasitology, prevention & control]; 10. *Pregnancy Complications, Parasitic [drug therapy, etiology]; 11. Pregnancy Outcome; 12. Pregnancy Trimester, Second; 13. Pregnancy Trimester, Third; 14. Randomized Controlled Trials as Topic; 15. *Soil [parasitology]; | Provide MESH terms for the study
Effect of mass deworming with antihelminthics for soil‐transmitted helminths during pregnancy | You are a research assistant. Based on the question please provide appropriate answers |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.